IBX
IMAGION BIOSYSTEMS LIMITED
$0.0070
0.00%
Market cap
$6M
Turnover
$13,892
Last price
$0.0070
Day change
0.00%
Announcements
8
Range, past year
Open 0.038 · Low 0.007 · Now 0.007 · High 0.055
Open IBX in the full dashboard →
Charts, screener, momentum and signals across every ASX-listed code.
IBX momentum and trend analysis
Our analysis
Independent analysis generated by Stock Trade Intelligence
as at 2026-09-28.
Momentum quality
23/100
Wyckoff phase
Accumulation6d
Trend stage
Neutral
1 Day
+0.0%
1 Week
-12.5%
1 Month
-22.2%
1 Year
-82.9%
RSI
25
Avg daily range
10.1%
IMAGION BIOSYSTEMS LIMITED scores 23 out of 100 for momentum quality, a reading rated very low confidence. The score weighs trend structure, price consistency, volume backing and how long the move has held, so a high reading means a sustained trend rather than a single large day. Its trend is currently classified as Neutral.
On the Wyckoff cycle it sits in Accumulation, where it has been for 6 trading days. The weekly timeframe reads Downtrend, which does not yet agree with the daily view.
Against the wider market it is currently underperforming and the institutional accumulation signal reads low.
Points to watch
- RSI oversold (25)
- 60d drawdown -46.2%
- High volatility (ATR 10.1%)
- Thin liquidity
- Risk rating: Very High
IBX announcements
Recent price-sensitive releases.
- 2026-09-14 MagSense Nanoparticle Manufacturing Update Progress Report
- 2026-08-26 IBX Phase 2 Clinical Trial Update Progress Report
- 2026-08-24 Appendix 4D and Half-yearly Financial Report Half Yearly Report | Half Year Audit Review | Half Year Directors' Statement | Half Year Accounts | Half Year Directors' Report
- 2026-07-31 Appendix 4C and Quarterly Activities Report - June 2026 Commitments Test Entity - Second Quarter Activity Report | Commitments Test Entity - Second Quarter Cashflow Report
- 2026-06-25 IBX Secures Firm Commitments for $3.75m for Clinical Trial
- 2026-06-23 Trading Halt
- 2026-06-02 Imagion Biosystems Receives IND Clearance from US FDA
More Health Care stocks
Most traded in the same sector.